Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/82531
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease |
Author: | Parkes, J. Roderick, P. Harris, S. Day, C. Mutimer, D. Collier, J. Lombard, M. Alexander, G. Ramage, J. Dusheiko, G. Wheatley, M. Gough, C. Burt, A. Rosenberg, W. |
Citation: | Gut, 2010; 59(9):1245-1251 |
Publisher: | British Med Journal Publ Group |
Issue Date: | 2010 |
ISSN: | 0017-5749 1468-3288 |
Statement of Responsibility: | Julie Parkes, Paul Roderick, Scott Harris, Christopher Day, David Mutimer, Jane Collier, Martin Lombard, Graeme Alexander, John Ramage, Geoffrey Dusheiko, Mark Wheatley, Carol Gough, Alastair Burt, William Rosenberg |
Abstract: | BACKGROUND Clinicians use fibrosis in a liver biopsy to predict clinical outcomes of chronic liver disease. The performance of non-invasive tests has been evaluated against histological assessment of fibrosis but use of clinical outcomes as the reference standard would be ideal. The enhanced liver fibrosis (ELF) test was derived and validated in a large cohort of patients and shown to have high diagnostic accuracy (area under the curve (AUC)=0.80 95% CI 0.76 to 0.85) in identification of significant fibrosis on biopsy. OBJECTIVE To evaluate ELF performance in predicting clinical outcomes by following up the original ELF cohort. METHODS Patients recruited to the ELF study at seven English centres were followed up for liver morbidity and mortality by examination of clinical data. Defaulting/discharged patients were followed up by family practitioner questionnaires. Primary outcome measure was liver-related morbidity/liver-related death. RESULTS 457 patients were followed up (median 7 years), with ascertainment of clinical status in 92%. There were 61 liver-related outcomes (39 deaths). Survival analysis showed that the ELF score predicts liver outcomes, with people having the highest ELF scores being significantly more likely to have clinical outcomes than those in lower-score groups. A Cox proportional hazards model showed fully adjusted HRs of 75 (ELF score 12.52–16.67), 20 (10.426–12.51) and 5 (8.34–10.425) compared with patients with ELF <8.34. A unit change in ELF is associated with a doubling of risk of liver-related outcome. CONCLUSIONS An ELF test can predict clinical outcomes in patients with chronic liver disease and may be a useful prognostic tool in clinical practice. |
Keywords: | Liver Humans Liver Cirrhosis Chronic Disease Biopsy Prognosis Epidemiologic Methods Adolescent Adult Aged Middle Aged Female Male Young Adult Biomarkers Outcome Assessment, Health Care |
Rights: | Copyright status unknown |
DOI: | 10.1136/gut.2009.203166 |
Published version: | http://gut.bmj.com/content/59/9/1245.long |
Appears in Collections: | Aurora harvest 4 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.